Abstract. Intercellular adhesion molecule (ICAM)-3, a recently described counter-receptor for the lymphocyte function-associated antigen (LFA)-I integrin, appears to play an important role in the initial phase of immune response. We have previously described the involvement of ICAM-3 in the regulation of LFA-1/ ICAM-l-dependent cell-cell interaction of T lymphoblasts. In this study, we further investigated the functional role of ICAM-3 in other leukocyte cell-cell interactions as well as the molecular mechanisms regulating these processes. We have found that ICAM-3 is also able to mediate LFA-1/ICAM-I-independent cell aggregation of the leukemic JM T cell line and the LFA-1/CD18-deficient HAFSA B cell line. The ICAM-3-induced cell aggregation of JM and HAFSA cells was not affected by the addition of blocking mAb specific for a number of cell adhesion molecules such as CDlla/CD18, ICAM-1 (CD54), CD2, LFA-3 (CD58), very late antigen t~4 (CD49d), and very late antigen/~1 (CD29). Interestingly, some mAb against the leukocyte tyrosine phosphatase CD45 were able to inhibit this interaction. Moreover, they also prevented the aggregation induced on JM T cells by the proaggregatory anti-LFA-lot NKI-L16 mAb. In addition, inhibitors of tyrosine kinase activity also abolished ICAM-3 and LFA-l-mediated cell aggregation. The induction of tyrosine phosphorylation through ICAM-3 and LFA-1 antigens was studied by immunofluorescence, and it was found that tyrosinephosphorylated proteins were preferentially located at intercellular boundaries upon the induction of cell aggregation by either anti-ICAM-3 or anti-LFA-lot mAb. Western blot analysis revealed that the engagement of ICAM-3 or LFA-1 with activating mAb enhanced tyrosine phosphorylation of polypeptides of 125, 70, and 38 kD on JM cells. This phenomenon was inhibited by preincubation of JM cells with those anti-CD45 mAb that prevented cell aggregation. Altogether these results indicate that CIM5 tyrosine phosphatase plays a relevant role in the regulation of both intracellular signaling and cell adhesion induced through ICAM-3 and/32 integrins.
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EUKOCYTE ~/2 integrins (lymphocyte function-associated
antigen [LFA]I-1, Mac-l, and p150,95) (Hynes, R. O., 1992) are one of the most important families of adhesion molecules involved in immune response. Three counter-receptors for LFA-1, which belong to the immunoglobulin superfamily, have been described: intercellular adhesion molecule (ICAM)-I, a widespread and cytokineinducible molecule; ICAM-2, constitutively expressed in several cell types but noninducible; and ICAM-3, that has recently been characterized (de Fougerolles and Springer, 1992) . ICAM-3 (CD50) contains five Ig domains and it is 1. Abbreviations used in this paper: ICAM, intercellular adhesion molecules; IL, interleukin; LFA, lymphocyte function-associated antigen; PHA, phytohaernagglntinin; RT, room temperature; VLA, very late antigen. structurally homologous to ICAM-1 and -2 (Fawcett et al., 1992; Vazeux et al., 1992; de Fougerolles et al., 1993) . ICAM-3 expression is restricted to the leukocyte cell lineage, and its presence on resting T cells points out to a role for this antigen in the initial phases of immune response (de Fougerolles and Springer, 1992; Acevedo et al., 1993) . Recently, we have reported the ability of ICAM-3 to regulate both the LFA-1/ICAM-l-dependent homotypic aggregation of T lymphoblasts and the affinity of LFA-1 for ICAM-1 . Moreover, ICAM-3 induces T lymphocyte activation, expression of the activation antigens CD25 and CD69, and T cell proliferation Hermtndez-Caselles et al., 1993) .
The functional involvement of the integrin LFA-1 in adhesion events during the immune response has been well demonstrated. LFA-1 plays a role in T cell activation facilitating cell-cell interactions (Springer, T.A., 1990) . In this regard, LFA-1 can be considered not only as one of the most important leukocyte adhesion molecules but also as an accessory coactivation receptor for antigen-driven T lymphocyte-mediated responses. We report herein the existence of an alternative ICAM-3-mediated intercellular adhesion pathway in human leukocytes that is independent of LFA-I/ICAM-1. This homotypic aggregation can be regulated by anti-CD45 tyrosine phosphatase mAb. We also demonstrated that this regulatory effect is related to the triggering of protein tyrosine phosphorylation through either ICAM-3 or LFA-1. The ICAM-3 and LFA-l-mediated enhancement of tyrosine phosphorylation is modulated by the CD45 tyrosine phosphatase.
Materials and Methods

Cells and Cell Lines
Human T leukemic JM and Jurkat cell lines were grown in RPMI 1640 medium (Whittaker Labs., Walkersville, MD) supplemented with 5% FCS (Semmed, Biokhrom, Berlin, Germany), 2 mM L-glutamine, 50 U/ml penicillin, and 50/~g/mi streptomycin (Semmed). The LFA-1/CD18-deficient HAFSA B cell line has been described ( L6pez-P.~Irlguez et al., 1993) .
Human T lymphoblasts were obtained from peripheral blood mononuclear ceils by treatment with phytohaemaggiutinin (PHA) at 5/~g/mi for 48 h. Then, cells were washed and cultured in RPMI 1640 (Whittaker Labs.) containing 10% FCS, and 50 U/mi IL-2. T lymphoblasts cultured by 7-12 d were typically used in the experiments.
Mouse 300-19 pre-B cells fines tmnsfect~ with the pZipneo plasmid vector or with cDNAs coding for different CD45 isoforms containin~ either the constant region of CD45 alone or in combination with different protein regions encoded by the variable exous (ABC, AB, BC, and B isoforms) were kindly provided by Dr. Michel Streuli (Dana Farber Cancer Institute, Boston, MA) and grown as described (Streuli et al., 1988) .
Reagents
Genistein was purchased from Sigma Chem. Co. (St. Louis, MO). Herbymicin A and tyrphostin 25 were purchased from Calbiochem (La Jolla, CA).
Monoclonal Antibodies
Anti-ICAM-3 HP2/19 and TPl/25; anti-LFA-lc~ TP1/40 and NKI-LI6; anti-~2 Lia3/2; anti-CD3 SPV-T3b; anti-ICAM-1 RR1/I; anti-very late antigen (VLA)-4 HP2/1; anti-VLA-/~l TS2/16; anti-CD2 TS2/18; anti-LFA-3 TS2/9; and anti-CIM3 TP1/36 mAb have been described (S~nchez-Madrid et al., 1982 (S~nchez-Madrid et al., , 1986 Hemler et al., 1984; Spits et al., 1985; Keizer et al., 1988; Campanero et al., 1991 Campanero et al., , 1993 . The anti-CD45 TPI/41 mAb was obtained in our laboratory from a fusion with splenocytes from mice immunized with activated human T lymphocytes and its precise specificity is described in this report. The other anti-CD45 mAb used in this study have been previously described (Pulido et al., 1988 (Pulido et al., , 1989 Zapata et al., 1994) . The anti-CD45RO UCHL.1 mAb was kindly provided by Dr. P. Beverley (Imperial Cancer Research Fund, London, U.K.). mAb were purified from ascites fluid using affinity chromatography on protein A-Sepherose column~ (Phermacia Fine Chemicals, Uppsala, Sweden). The anti-phosphotyrosine 4¢310 and Py20 mAb were purchased from Upstate Biotechnology (Lake Placid, NY) and ICN Biochemicals (Cleveland, OH), respectively.
Aggregation Assays
Homotypic cell aggregation assays were performed as previously described (Campanero et al., 1990) . Briefly, lO s cells/well were incubated in complete medium in flat-bottomed 96-well plates (Costar, Cambridge, MA) in the presence ofmAb (1 ~g/ml), and cells were allowed to settle at 37°C and 5 % CO2 atmosphere. Aggregation was then determined at different periods of time by direct visualization of the plate with an inverted microscope and counting free cells in at least five randomly chosen fields of 0.025 mm 2, using a special grid under the plate. The assays were performed by duplicate. Results were expressed as percent of aggregated cells. For inhibition assays, cells were pretreated with different mAb for 10 min at room temperature (RT) before the addition of the inducing mAb.
Immunoprecipitation
Cells were nSI-radiolabeled, lysed, and immunoprecipitated with different monoclonal antibodies as previously described (S(mchez-Medrid et al., 1983) . Samples were subjected to SDS-7% PAGE under nonreducing conditions.
Cytofluorometry Analysis
Fluorescence flow cytometry analysis was performed on a FACScan cytofluorometer (Becton Dickinson, Mountain View, CA). Cells were incubated at 4*C with 100 ~tl hybridoma culture supernatant, followed by washing and labeling with and F r r C -~e d goat anti-mouse Ig (Dttvpet¢, Copenhage~ , Denmark). Data were collected in a logarithm/c scale and the percentage of positive cells was determined by ~ the fluorescence given by the negative control mouse myeloma P3X63.
Immunofluorescence Staining
JM cells were incubated in flat-bottomed, 24-well mlcrotiter plates (Coster) at 2 x 106 cells/mi in a final volume of 500/d of complete medium, mAb were added at a final concentration of 1 ;tg/nd and cells were allowed to settle in an incubator at 37°C and 5% CO2 atmosphere. After the induction of aggregation, the cells were fixed with 3.7% formaldehyde in PBS for 10 rain RT and rinsed in TBS (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 0.1% NAN3). To directly visualize the mAb-inducing cell aggregation, 1:50 dilution of the FITC-laheled rabbit F (ab92 anti-mouse IgG (Pierce Chemical Co., Rockford, IL) was ~da~. In order to detect tymsine-phosphorylated proteins, cells were fixed and permeabilized with 0.2% Triton X-100. Then cell aggregates were incubated with biotinylated anti-phosphotyrosine Py20 mAb (ICN Biochemicals, Inc., Costa Mesa, CA) at a final concenffafion of 1 ~8/ml. The cells were washed and incubated with an 1:1,000 dilution of TRrIC-avidin D (Vector, Burllngmne, CA), then with an 1:100 dilution of anti-avidin D-biotin (Vector), and again with an 1:1,000 dilution of TRrIC-avidin D (Vector). Cells were observed using a Nikvn Labophot-2 photomicruscope with a 60 × oil immersion objective and photographed on TMAX 400 film (Eastman ~ Co., Rochester, NY) processed to 800-1600 ASA with TMAX developer (Easmum Kodak Co.).
Western Blot Analysis
JMcells (5-I0 × I06) were incubated in culttwe medium in presence of activatin8 mAb for 5 min on ice bath. In some ezpefime~, the cells were pretreated with ~ anfi-CD45 mAb for 1 min at RT. A sheep anti-mouse Ig (Sigma Chem. Co.) at 20 ~g/mi wus used as crms-linker during the time indic~_t_ed~. After stimulation, cells were lysed by adding a buffer containin~ 137 mM NaCI, 20 mM Tris, pH 7.5, 1 mM MgCI2, 1 mM CaCl2, 10% glycerol, 1% NP-40, 150/~M sodium orthowmulm,, 1/tg/mi leupaptin, and 1 mM PMSF during 15 min on ice, and then centrifuged. Lysates were incubated with the anti-phosphotyrosine Py72 mAb at 5 /~g/sample and imm,mocomplexes were then isolated by addition of 187.1 anti-mouse kappa chain mAb and protein A-Sephasose. After washing, phosphoproteins were specifically ehted by 20 mM phenylphosphate incubation. Then samples were subjected to SDS-8 % P A G E under reducing conditions and electrou'ansferred onto Immobilon-P membrane (Millipore, Bedford, IdA) in Tris-Glycine-Methanol as buffer, for 12 h at 0.2 A, 50 V at 4oc. After blocking the membrane with 10% BSA in TBS (20 mM Tris, pH 7.5, 150 mM NaCI), protein bands were visualized by incubation with an 1251 anfi-phosphotyrosine 4G10 mAb (Upstate Biotechnology, Inc., lake Placid, NY), about 106 cpm/ml during 2 h. Membranes were exposed to AGFA Curix film, and developed after 48 h.
Results
Homotypic Cell Aggregation Induced by Anti-ICAM-3 mAb Involves LFA-1/ICAM-1--dependent and-independent Pathways
To ascertain the role of ICAM-3 in leukocyte intercellular interactions, we studied the ability of anti-ICAM-3 mAb to induce intercellular adhesion in normal T lymphoblasts, leukemic JM T cells, and HAFSA B cells which are deficient for /32 integrins. As shown in Fig. 1 , the anti-ICAM-3 HP2/19 mAb was capable to induce cell aggregation of the three different cell types (Fig. 1, top) . In contrast, the anti-ICAM-3 TP1/25 rnAb, that recognizes a different epitope than HP2/19 , did not aggregate these cells (Fig. 1, bottom) .
We have previously reported that the ICAM-3-induced cell aggregation of T lymphoblasts is LFA-1/ICAM-1 dependent . Since HAFSA cells do not express LFA-1, the only counter-receptor described for ICAM-3, it is possible that other adhesion molecular pathways could be involved in the intercellular interaction triggered by ICAM-3. Therefore, we tested several blocking rnAb directed to adhesion receptors involved in leukocyte interactions, including CD2, LFA-3, LFA-1, ICAM-1, VLA~4, and VLA/~I. As shown in Table I , cell aggregation induced by the anti-ICAM-3 HP2/19 mAb in JM and HAFSA cells was inhibited with another anti-ICAM-3 mAb, but not with mAb against any of the other adhesion molecules explored. In T lymphoblasts, the induced cell aggregation was also inhibited by mAb anti-ICAM-1 and anti-LFA-1 (Table I) , as JM cells were prelncubated with the different mAb indicated prior to the addition of the proaggregatory anti-ICAM-3 H_P2/19 mAb. Cell aggregation was quantified as described under Materials and Methods at 2 h, 30 rain, and 5 h for JM, HAFSA, and T blasts, respectively. Arithmetic mean of six independent experiments performed in duplicate is shown. SD was less than 10%.
previously described . Anti-CD2, anti-LFA-3, anti-VLAt~4, and anti-VLAfll mAb showed no inhibitory effect on any of the different cell types tested (Table I). Altogether, these data indicated the existence of two different pathways involved in homotypic lymphocyte aggregation triggered through ICAM-3, including both LFA-1/ICAM-1-dependent and -independent interactions.
The CD45 I)~osine Phosphatase Regulates ICAM-3-induced Intercellular Adhesion on JM Cells
To identify the molecules involved in the regulation of ICAM-3-mediated homotypic cell aggregation, a wide number of mAb of different specificities was screened by their ability to inhibit the anti-ICAM-3-triggered cell aggregation of JM cells. Interestingly, one mAb, termed TP1/41, was able to abrogate this intercellular adhesion phenomenon (Fig. 2  B) . Anti-ICAM-3 TP1/25 and anti-LFA-lot TP1/40 mAb were included as positive and negative control for inhibition ( Fig. 2C and D, respectively) . The viability of cells was not affected after treatment with these mAb as assessed by trypan blue exclusion (data not shown). The specificity of the TP1/41 mAb was investigated by immunoprecipitation assays from t2q-labeled Jurkat cell lysates. The pattern of polypeptides precipitated by the TP1/41 mAb (Fig. 3, lanes 1 and 2) was identical to that obtained with the anti-CD45 D3/9 mAb (Fig. 3, lane 3) . The specificity of the TP1/41 mAb was further demonstrated by analyzing its reactivity with cells transfected with cDNAs encoding for the different isoforms of the CD45 antigen. As shown in Table II , the TP1/41 mAb recognized cells transfected with any isoform of CD45 but not the mock-transfected cells. These data demonstrated that the specificity of the TP1/41 mAb was coincident with that of conventional anti-CIM5 mAb.
The ability of other anti-CD45 mAbs to inhibit ICAM-3-triggered homotypic cell aggregation was also tested. The conventional anti-CD45 D3/9 and HP2/23 mAb and the anti-CD45RB RP2/21 mAb were also able to inhibit the aggregation of JM cells (Table 111 ). In contrast, other conventional anti-CIM5 mAb and mAb that recognize other isoforms of CD45 did not exert any inhibitory effect (Table HI, JM cells were preincubated with different anti-CD45 mAb for 10 rain at RT before the addition of the proaggregatory anti-ICAM-3 HP2/19 mAb. Cell aggregation was quantified after 2 h. Arithmetic mean of three independent experiments performed by duplicate is shown. SD was less than 10%.
[32 Integrin-induced JM T Cell Aggregation Is Also Regulated through CD45 Phosphatase
We next investigated whether anti-CIM5 TP1/41 mAb also regulates JM cellular aggregation induced through antigens different from ICAM-3. To this end, the proaggregatory anti-LFA-la NKI-L16 mAb was used to induce aggregation of JM eels. As shown in Fig. 4 , the anti-CD45 TPI/41 mAb was able to inhibit this intercellular adhesion pathway. A similar blocking effect of the TP1/41 mAb was observed on the cell aggregation triggered by the anti-if2 KIM127 mAb (Robinson et al., 1992 ) (data not shown). In contrast, other cellular aggregation pathways including that triggered by the anti-CD43 TP1/36 mAb were unaffected by the anti-CD45 TP1/41 mAb (Fig. 4) .
l~rosine Phosphorylation Is Induced in Cell-CeU Contacts upon ICAM-3-and LFA-l-triggered JM Cell Aggregation
The CD45 molecule displays tyrosine phosphatase activity in its cytoplasmatie tail (Trowbridge, 1991) . The results shown above, indicating the inhibitory effects of anti-CIM5 mAb on ICAM-3-and LFA-l-triggered JM cell aggregation might be related to this enzymatic activity. Therefore, we investigated the possibility that the induction of JM cell aggregation through ICAM-3 and LFA-1 antigens could correlate with triggering of protein tyrosine phosphorylation. In this regard, the presence of tyrosine-phosphorylated proteins at intercellular contacts on cell aggregates induced through ICAM-3 or LFA-lo~ NKI-L16 mAb was easily detected by immunofluorescence (Fig. 5 a, A and B, respectively) . The ICAM-3 and LFA-1 antigens were also detected in cell-cell boundaries, as assessed by using the HP2/19 and the NKI-LI6 mAb (Fig. 5 b, A and B, respectively). These data suggest a direct involvement of these molecules in the triggering of tyrosine phosphorylation. Moreover, similar results were obtained when ceil aggregation was studied on normal T lymphoblasts (data not shown). Although tyrosine pbospborylation was induced on both JM T ceils and T lymphoblasts upon ICAM-3 or LFA-1 mediated aggregation, no : '°° regulatory effect of anti-CD45 mAb was observed on T : blasts, thus reinforcing the existence of different intracellular . signaling pathways in these two cell types. ~ ICAM-3-and LFA-l-mediated homotypic aggregation was inhibited by pretreatment of JM cells with the tyrosine-= kinase inhibitors herbymicin A, tyrphostin 25, and genistein o in a dose-dependent manner (Fig. 6) . In contrast, the CD43-~ ~o mediated aggregation was almost unaffected (Fig. 6) . Altogether these results indicate that protein tyrosine phosphorylation is an important intracellular signaling event during ICAM-3-and LFA-l-triggered homotypic cell aggre-~,hbb~,o~: gation, and suggest a role for the tyrosine phosphatase activity of CD45 in regulating these processes, s,~o~ :
CD45 Regulates the ~yrosine Phosphorylation Induced by Engagement of lCAM-3 or LFA-1 on JM T Cells
Western blot studies were performed to investigate the changes in the tyrosine phosphorylation protein pattern upon cell treatment with proaggregatory anti-ICAM-3 and anti-LFA-1 mAb. As shown in Fig. 7 A, the e n~m e n t of ICAM-3 or LFA-1 molecules with the HP2/19 and NKI-L16 mAb, respectively, induced the enhancement of tyrosine phosphorylation of several polypeptides of 125, 70, and 38 kD. The kinetics of this effect was very rapid, beginning after 1 rain and declining after 15 rain of either ICAM-3 or LFA-1 crosslinking (Fig. 7 A) . The pbosphorylation pattern induced through LFA-1 or ICAM-3 resembled that triggered through the CD3/ TcR complex but at lower degree (Fig. 7 A) . Preincubation 1-4, respectively) . Phosphoproteins were analyzed as described under Materials and Methods. Note the enhanced intensity of bands corresponding to 125, 70, and 38 kD when anti-CD3, HP2/19, or NKI-L16 were used as stimulus. A representative out of six independent experiments is shown. In some analysis, the phosphoproteins of 38 kD were resolved into two bands. (B) J i cells were preincubated with medium alone or 10/~g/ml of either TPI/41, D3/9, or RP1/10 mAb (lanes 1--4, respectively) 1 min at RT before addition of either medium alone or 1 /zg/ml anti-ICAM-3 HP2/19, or anti-LFA-lc~ NKI-L16 mAb for 5 min on ice. Then, sheep anti-mouse Ig was added during 3 min at 370C, and phosphoproteins were analyzed as described under Materials and Methods. Note that preincubation with the anti-tiM5 TP1/41 or D3/9 mAb inhibited the induction of phosphotyrosine of polypeptides of 125, 70, and 38 kD with no modifications of other bands. The anti-tiM5 RPI/10 exerted no effect. Preincnhation of JM cells with 50/~g/ml of genistein for 30 min at 37°C before addition of the different stimuli is also included (lane 5). A representative experiment out of four independent ones is shown.
of JM cells with the tyrosine kinase inhibitor genistein abrogated the induction of tyrosine phosphorylation through these adhesion molecules (Fig. 7 B, lane 5) .
To further explore the role of CD45 in the regulation of ICAM-3-and LFA-l-triggered intracellular signaling, we performed the induction of tyrosine phosphorylation in the presence of different regulatory and nonregulatory anti-CD45 mAb. As observed in Fig. 7 B, preincubation with TP1/41 or D3/9 but not with the functionally irrelevant RP1/10 mAb prevented the tyrosine phosphorylation of the 125, 70, and 38 kD polypeptides induced by ICAM-3 or LFA-1 engagement. Moreover, the dephosphorylation effect induced by TP1/41 was abolished by preincubation of JM cells with the tyrosine phosphatase inhibitor phenylarsine oxyde (data not shown).
Altogether, these data indicate that ICAM-3 and LFA-1 trigger specific tyrosine phosphorylation of several cellular polypeptides, and that the CIM5 tyrosine phosphatase regulates this intracellular signaling pathway.
Discussion
In this report, we describe the existence of an alternative pathway of anti-ICAM-3-induced lymphocyte homotypic aggregation which is LFA-1/ICAM-1 independent. This pathway, as well as that induced through LFA-1, triggers tyrosine phosphorylation, and is regulated by the CD45 tyrosine phosphatase. The diagram shown in Scheme 1 represents the possible events involved in these intracellular signaling pathways.
We have previously reported that the aggregation of T lymphoblasts triggered by ICAM-3 involves the activation of the LFA-1/ICAM-1 pathway . We have shown herein that anti-ICAM-3 can induce cell aggregation of both LFA-1 + cells and /32-deficient (LFA-1-) HAFSA cells, thus indicating that this molecule triggers an LFA-1/ICAM-l-independent cell adhesion pathway. The ICAM-3-mediated cell aggregation of LFA-1 + JM T or LFA-1-HAFSA B cells was not affected by cell prelxeatment with mAb against different molecules involved in intercellular interactions. Only an anti-ICAM-3 mAb recognizing a different epitope was able to inhibit this interaction. Crossinhibitory effects of mAb directed to different epitopes on the same molecule have already been reported for other antigens such as LFA-1, VLAa4, or VLA~I (Keizer et al., 1988; Pulido et al., 1991; Campanero et al., 1992) . Several mechanisms may account for the LFA-l-independent ICAM-3-induced homotypic cell aggregation including the existence of other ligands for ICAM-3, or the triggering of intracellular signals through ICAM-3 that would activate other adhesion molecules.
When searching for molecules involved in the regulation of the LFA-l-independent ICAM-3-induced cell aggregation, we found that the TPU41 mAb inhibited this process. Both immunoprecipitation analysis and binding assays with transfected cells revealed that this mAb is directed against the CD45 antigen. We have also demonstrated that this mAb, as well as other anti-CD45 mAb are able to inhibit the homotypic cell aggregation induced through either ICAM-3 or the LFA-1 integrin. In contrast, other intercellular adhesion pathways, as that induced by anti-CD43 mAb, remained unaffected, thus indicating that CD45 has a specific regula- The putative interaction between LFA-1 and ICAM-3 (*) in this system could be a transient one as recently reported for T blasts , since no blocking effects of anti-LFA-1 mAb are detected in anti-ICAM-3-triggered JM cell aggregation.
tory role in the aggregation events mediated by ICAM-3 and LFA-1. A minor inhibitory effect of these anti-CIM5 mAb was observed in VLA-4-mediated homotypic cell aggregation (A.G. Arroyo, unpublished observations). Since CD45 is a pan-leukocyte glycoprotein that contains two consensus domains of tyrosine-phosphatase in its cytoplasmic tail (Trowbridge, 1991) , we next investigated the role of tyrosine phosphorylation in ICAM-3 and LFA-1 intracellular signaling. Our results on ICAM-3-and LFA-l-mediated signaling by both immunofluorescence staining and Western blot analysis, indicate an increase of tyrosine phosphorylation of several proteins upon LFA-1 or ICAM-3 engagement. The induction of tyrosine phosphorylation of different proteins by the engagement of other integrin members from /31 and /33 subfamilies have recently been described (Burridge et al., 1992; Guan and Shalloway, 1992; Kornberg et al., 1992; Lipfert et al., 1992; Juliano and Haskill, 1993) . Moreover, it was recently reported that ot2~l integrin activation can result in tyrosine phosphorylation of 47-52 kD proteins as well as in activation of a signaling pathway involving p21 ~' (Kapron-Bras et al., 1993) . However, the induction of tyrosine phosphorylation by/32 leukocyte integrins or their ligands had not previously been investigated. The functional significance of this signaling pathway in leukocyte intercellular adhesion is reinforced by the inhibition of ICAM-3-and LFA-l-mediated homotypic aggregation by specific tyrosine kinase inhibitors (Scheme 1).
The nature of the 125, 70, and 38 kD proteins that become phosphorylated upon engagement of ICAM-3 or LFA-1 remains to be determined. Possible candidates of similar molecular masses would include proteins known to be phosphorylated through B1 or B3 integrins such as p125 f~ (125 kD) or paxillin (70 kD) (Burridge et al., 1992) , or those which are phosphorylated after activation through the CD3/TcR complex such as PLC3, (135 kD), the recently described ZAP-70 (70 kD), and different members of MAP kinase family (about 40 kD) (Nel et al., 1990a,b; Park et al., 1991; Secrist et al., 1991; Weiss et al., 1991; Chan et al., 1992; Whitehurst et al., 1992) . It would also be very interesting to investigate the putative tyrosine-kinases involved in this signaling pathway, but these issues deserve further research.
Regarding the mechanism accounting for the inhibitory effect of different anti-CIM5 mAb on anti-ICAM-3-and anti-LFA-l-induced JM T cell aggregation, it may involve a modulation of CD45 tyrosine phosphatase activity by engagement of CIM5 with mAb, as suggested by a decrease in tyrosine phosphorylation of different polypeptides in Western blot analysis. This might cause dimerization of the receptor that could regulate tyrosine phosphatase function by sequestration or dephosphorylation of tyrosine phosphatase domains, as it has been recently described (Desai et al., 1993) . Interestingly, two of the blocking anti-CD45 mAb, D3/9 and HP2/23, have been previously found that inhibit PHA-induced T lymphocyte proliferation (Bernabeu et al., 1987) . Recently, the regulatory role of CIM5 mAb in LFA-1-independent/tyrosine kinase-dependent B cell aggregation, and the inhibitory effect of these mAb on calcium mobilization induced through LFA-1 in NK cells have been described (Poggi et al., 1993; Wagner et al., 1993) . The tyrosine kinases likely involved in this regulation are not known yet. In this regard, it has been reported the activation of lck and fyn kinases in T lymphocytes by CD45-mediated dephosphorylation of tyrosine 505 and 531, respectively (Shiroo et al., 1992; Hurley et al., 1993) . Moreover, CIM5 tyrosine phosphatase is also able to regulate activation of MAP ldnase (Anderson et al., 1990; Nel et al., 1991) . The role that these kinases could play in ICAM-3-and LFA-1-triggered signaling deserves further research.
In summary, we have provided data demonstrating the existence of LFA-I/ICAM-l-independent homotypic cell aggregation induced by anti-ICAM-3 mAb in different cell lines. Remarkably, this interaction could be regulated by the CD45 tyrosine phosphatase, and this fact is related to the ability of ICAM-3 and LFA-I antigens to induce tyrosine phosphorylation of different cellular substrates (Scheme I).
